BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Long term liabilities

Annual long term liabilities:

$723.96M+$10.93M(+1.53%)
December 31, 2024

Summary

  • As of today (September 13, 2025), BMRN annual total long term liabilities is $723.96 million, with the most recent change of +$10.93 million (+1.53%) on December 31, 2024.
  • During the last 3 years, BMRN annual long term liabilities has fallen by -$468.80 million (-39.30%).
  • BMRN annual long term liabilities is now -42.06% below its all-time high of $1.25 billion, reached on December 31, 2020.

Performance

BMRN Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

quarterly long term liabilities:

$744.98M+$19.65M(+2.71%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BMRN quarterly total long term liabilities is $744.98 million, with the most recent change of +$19.65 million (+2.71%) on June 30, 2025.
  • Over the past year, BMRN quarterly long term liabilities has increased by +$31.50 million (+4.41%).
  • BMRN quarterly long term liabilities is now -44.80% below its all-time high of $1.35 billion, reached on September 30, 2017.

Performance

BMRN quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

BMRN Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.5%+4.4%
3 y3 years-39.3%-36.7%
5 y5 years+14.0%-40.5%

BMRN Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-39.3%+1.5%-37.0%+6.7%
5 y5-year-42.1%+14.0%-40.5%+6.7%
alltimeall time-42.1%+576.2%-44.8%+590.1%

BMRN Long term liabilities History

DateAnnualQuarterly
Jun 2025
-
$744.98M(+2.7%)
Mar 2025
-
$725.34M(+0.2%)
Dec 2024
$723.96M(+1.5%)
$723.96M(+0.3%)
Sep 2024
-
$722.14M(+1.2%)
Jun 2024
-
$713.49M(+0.4%)
Mar 2024
-
$710.96M(-0.3%)
Dec 2023
$713.03M(-39.7%)
$713.03M(+2.1%)
Sep 2023
-
$698.04M(-41.0%)
Jun 2023
-
$1.18B(+0.6%)
Mar 2023
-
$1.18B(-0.6%)
Dec 2022
$1.18B(-0.8%)
$1.18B(+0.7%)
Sep 2022
-
$1.17B(-0.2%)
Jun 2022
-
$1.18B(-0.4%)
Mar 2022
-
$1.18B(-1.0%)
Dec 2021
$1.19B(-4.5%)
$1.19B(-0.3%)
Sep 2021
-
$1.20B(-1.4%)
Jun 2021
-
$1.21B(+0.0%)
Mar 2021
-
$1.21B(-2.9%)
Dec 2020
$1.25B(+96.7%)
$1.25B(-0.0%)
Sep 2020
-
$1.25B(-0.2%)
Jun 2020
-
$1.25B(+89.0%)
Mar 2020
-
$662.41M(+4.3%)
Dec 2019
$635.15M(+279.0%)
$635.15M(-35.8%)
Sep 2019
-
$989.98M(-0.3%)
Jun 2019
-
$993.00M(-0.5%)
Mar 2019
-
$997.78M(+495.3%)
Dec 2018
$167.60M(-29.8%)
$167.60M(-82.2%)
Sep 2018
-
$941.65M(+0.8%)
Jun 2018
-
$934.63M(-8.0%)
Mar 2018
-
$1.02B(+325.7%)
Dec 2017
$238.75M(-70.8%)
$238.75M(-82.3%)
Sep 2017
-
$1.35B(+58.8%)
Jun 2017
-
$850.08M(+2.5%)
Mar 2017
-
$829.31M(+1.4%)
Dec 2016
$818.11M(+270.6%)
$818.11M(-0.1%)
Sep 2016
-
$819.10M(+1.7%)
Jun 2016
-
$805.15M(+151.0%)
Mar 2016
-
$320.74M(+45.3%)
Dec 2015
$220.78M(-69.6%)
$220.78M(-19.4%)
Sep 2015
-
$273.93M(-3.0%)
Jun 2015
-
$282.54M(+3.8%)
Mar 2015
-
$272.23M(-62.5%)
Dec 2014
$726.82M(+0.3%)
$726.82M(+0.2%)
Sep 2014
-
$725.44M(+1.2%)
Jun 2014
-
$717.00M(-1.0%)
Mar 2014
-
$724.57M(-0.0%)
Dec 2013
$724.90M(+700.2%)
$724.90M(+638.9%)
Sep 2013
-
$98.10M(+7.6%)
Jun 2013
-
$91.20M(-3.3%)
Mar 2013
-
$94.28M(+4.1%)
Dec 2012
$90.59M(+2.7%)
$90.59M(-2.0%)
Sep 2012
-
$92.39M(+5.9%)
Jun 2012
-
$87.24M(+8.4%)
Mar 2012
-
$80.45M(-8.8%)
DateAnnualQuarterly
Dec 2011
$88.18M(-158.0%)
$88.18M(-0.9%)
Sep 2011
-
$88.94M(-163.6%)
Jun 2011
-
-$139.87M(-1.6%)
Mar 2011
-
-$142.15M(-6.5%)
Dec 2010
-$152.02M(-129.4%)
-$152.02M(-318.1%)
Sep 2010
-
$69.69M(+67.8%)
Jun 2010
-
$41.54M(-92.3%)
Mar 2010
-
$542.27M(+4.9%)
Dec 2009
$516.82M(+3.4%)
$516.82M(+3.1%)
Sep 2009
-
$501.43M(+0.1%)
Jun 2009
-
$500.97M(+0.2%)
Mar 2009
-
$500.03M(+0.0%)
Dec 2008
$499.94M(-11.7%)
$499.94M(-0.1%)
Sep 2008
-
$500.40M(-11.4%)
Jun 2008
-
$565.11M(-0.0%)
Mar 2008
-
$565.23M(-0.1%)
Dec 2007
$566.01M(+88.9%)
$566.01M(-0.3%)
Sep 2007
-
$567.45M(-0.4%)
Jun 2007
-
$569.49M(+131.3%)
Mar 2007
-
$246.22M(-17.8%)
Dec 2006
$299.59M(+28.9%)
$299.59M(-0.7%)
Sep 2006
-
$301.73M(-21.0%)
Jun 2006
-
$381.82M(-0.9%)
Mar 2006
-
$385.34M(+65.8%)
Dec 2005
$232.40M(+0.7%)
$232.40M(+1.0%)
Sep 2005
-
$230.00M(-1.7%)
Jun 2005
-
$233.99M(+6.1%)
Mar 2005
-
$220.47M(-4.5%)
Dec 2004
$230.89M(+83.7%)
$230.89M(+3.8%)
Sep 2004
-
$222.35M(-0.3%)
Jun 2004
-
$222.96M(+77.8%)
Mar 2004
-
$125.36M(-0.2%)
Dec 2003
$125.67M(+2304.7%)
$125.67M(-0.4%)
Sep 2003
-
$126.24M(-1.9%)
Jun 2003
-
$128.70M(+2762.5%)
Mar 2003
-
$4.50M(-14.0%)
Dec 2002
$5.23M(+31.9%)
$5.23M(+79.5%)
Sep 2002
-
$2.91M(-15.9%)
Jun 2002
-
$3.46M(-1.1%)
Mar 2002
-
$3.50M(-11.6%)
Dec 2001
$3.96M(+6973.2%)
$3.96M(+2613.0%)
Sep 2001
-
$146.00K(-26.3%)
Jun 2001
-
$198.00K(+321.3%)
Mar 2001
-
$47.00K(-16.1%)
Dec 2000
$56.00K(-34.1%)
$56.00K(-11.1%)
Sep 2000
-
$63.00K(-7.4%)
Jun 2000
-
$68.00K(-11.7%)
Mar 2000
-
$77.00K(-9.4%)
Dec 1999
$85.00K(-22.7%)
$85.00K(-15.0%)
Sep 1999
-
$100.00K(-99.6%)
Jun 1999
-
$26.10M(>+9900.0%)
Mar 1999
-
$100.00K(-9.0%)
Dec 1998
$110.00K(>+9900.0%)
-
Dec 1998
-
$109.90K
Dec 1997
$0.00
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual total long term liabilities?
  • What is the all time high annual long term liabilities for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual long term liabilities year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly long term liabilities year-on-year change?

What is BioMarin Pharmaceutical Inc. annual total long term liabilities?

The current annual long term liabilities of BMRN is $723.96M

What is the all time high annual long term liabilities for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual total long term liabilities is $1.25B

What is BioMarin Pharmaceutical Inc. annual long term liabilities year-on-year change?

Over the past year, BMRN annual total long term liabilities has changed by +$10.93M (+1.53%)

What is BioMarin Pharmaceutical Inc. quarterly total long term liabilities?

The current quarterly long term liabilities of BMRN is $744.98M

What is the all time high quarterly long term liabilities for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly total long term liabilities is $1.35B

What is BioMarin Pharmaceutical Inc. quarterly long term liabilities year-on-year change?

Over the past year, BMRN quarterly total long term liabilities has changed by +$31.50M (+4.41%)
On this page